Cargando…

Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)

BACKGROUND: Staphylococcus aureus causes serious health care– and community-associated disease, requiring improved preventive measures such as vaccines. The investigational S. aureus 4-antigen vaccine (SA4Ag), comprising capsular polysaccharide serotypes 5 and 8 (CP5 and CP8) conjugated to CRM(197),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Creech, C Buddy, Frenck, Robert W, Fiquet, Anne, Feldman, Robert, Kankam, Martin K, Pathirana, Sudam, Baber, James, Radley, David, Cooper, David, Eiden, Joseph, Gruber, William C, Jansen, Kathrin U, Anderson, Annaliesa S, Gurtman, Alejandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978999/ https://www.ncbi.nlm.nih.gov/pubmed/31993453 http://dx.doi.org/10.1093/ofid/ofz532

Ejemplares similares

599 Rapid rises in antibody titers observed following single dose administration of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) to healthy adults
por: Frenck, Robert W., et al.
Publicado: (2014)

Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults
por: Inoue, Megumi, et al.
Publicado: (2018)

Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
por: Hassanzadeh, Hamid, et al.
Publicado: (2023)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
por: Peterson, James T, et al.
Publicado: (2021)

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults
por: Baber, James, et al.
Publicado: (2022)

A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
por: Walsh, Edward E, et al.
Publicado: (2021)

Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?
por: Anderson, Evan J, et al.
Publicado: (2020)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
por: Baber, James A, et al.
Publicado: (2023)

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years
por: Essink, Brandon, et al.
Publicado: (2021)

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
por: Falsey, Ann R, et al.
Publicado: (2021)

M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain( )
por: Eiden, Joseph, et al.
Publicado: (2021)

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022)

Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines
por: Ambrosino, Donna, et al.
Publicado: (2021)

Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study
por: Scully, Ingrid Lea, et al.
Publicado: (2017)

Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose
por: Dagan, Ron, et al.
Publicado: (2020)

Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine
por: Harris, Shannon L., et al.
Publicado: (2020)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection
por: Anderson, Annaliesa S., et al.
Publicado: (2016)

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV
por: Reilly-Evans, Brenna, et al.
Publicado: (2023)

Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination
por: Loeb, Nathalie, et al.
Publicado: (2020)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
por: Absalon, Judith, et al.
Publicado: (2022)

Getting Personal: How Childhood Vaccination Policies Shape the Landscape of Vaccine Exemptions
por: Garnier, Romain, et al.
Publicado: (2020)

Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011–2016
por: Omer, Saad B, et al.
Publicado: (2017)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development
por: Diemert, David, et al.
Publicado: (2018)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Vaccination Coverage and Risk Factors Associated With Incomplete Vaccination Among Children in Cambodia, Madagascar, and Senegal
por: Verrier, Florian, et al.
Publicado: (2023)

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
por: Jongkees, Marlou J, et al.
Publicado: (2022)

Genome sequencing and annotation of Morganella sp. SA36
por: Selim, Samy, et al.
Publicado: (2015)

Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction
por: Lartey, Sarah, et al.
Publicado: (2020)

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis
por: Okoli, George N, et al.
Publicado: (2021)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey
por: Chang, Andres, et al.
Publicado: (2021)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019
por: Park, Hailey J, et al.
Publicado: (2023)

2280. Antibiotic Exposure Does Not Impact Serological Responses to Rotavirus Vaccination
por: Anderson, Evan J, et al.
Publicado: (2018)

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
por: Haidar, Ghady, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bhbr2jtfill04v5qubul8eh18k